GT Biopharma, Inc. (GTBP) Total assets 2016–2020
GT Biopharma, Inc. (GTBP) total assets at each fiscal year-end, per SEC filings.
$5.7MFY2020 · since FY2016: $25,000 → $5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $5.7M | +1329.5% |
| FY2019 | $396,000 | — |
| FY2017 | $254.4M | +1017372.0% |
| FY2016 | $25,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GTBP financial trends
GTBP RevenueGTBP Net incomeGTBP Net marginGTBP Gross profitGTBP Gross marginGTBP Operating incomeGTBP Operating marginGTBP Operating cash flowGTBP Free cash flowGTBP Capital expendituresGTBP Return on equityGTBP Stock buybacksGTBP Dividends paidGTBP Total liabilitiesGTBP Shareholders’ equityGTBP overview →